Aurora Cannabis Inc T.ACB

Alternate Symbol(s): T.ACB.WS.U | ACB

Healthcare Cannabis

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.

TSX:ACB - Post by User

Aurora Cannabis Inc

Bullboard Posts

Comment by NB1017on Mar 29, 2019 11:52am

60 Views

Post# 29554582

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Aurora should Indirectly Buy Out Medmen

EXACTLY!!!!

12CenterLine wrote: Absolutely. That is one of the main reasons that I am attracted to Aurora. With something like 24 countries they are operating in now we are dealing with a global company now. So when the North American markets settle down Aurora already has it's foot in the door.

NB1017 wrote: True there will be a lot of work involved; However, because of the large global footprints that we have established, the mergers will be that more attractive to US LP's.

12CenterLine wrote: Yes it will be interesting. Definitly a large carylist. I think Aurora and Canopy will have their work cut out for them. Since the US has had multiple states legal for quite a while now and they have developed large multi state operators it won't be very easy for the Canadian companies to take over. They will have their work cut out for them.

NB1017 wrote: NP. This is only an hypothetical conversation, but anything could happen. When they finally take Cannabis off the Schedule 1, the whirlwind of mergers and acquisitions will be like none we have ever seen. The race to the top between Aurora and Canopy will be the most interesting.

12CenterLine wrote: Ah. Sorry my bad. I didn't catch that you mentioned that. Australis has made significant investments in Body and Mind to be their largest investment as a multi state operator. I think they are up to 4 states now.

NB1017 wrote: I had mentioned Australis in my opening remark, to fund purchasethrough Australis or Choom.

12CenterLine wrote: Aurora is already working on the US market through it's spin off company Australis. Australis is executing Aurora's US plan. With ACB holding warrants to either purchase Majority or all of the outstanding shares, I can't remember off the top of my head, they are already setting up for the US.

NB1017 wrote: Like it or not, Aurora, Canopy Growth, and others are waiting for opportunities to move in on the US market, once the FEDs clear the way with legalization. Thanks

Auctioneer wrote: Why on earth would you wish for Aurora to buy more stuff? It has bought plenty. If anything we should be wishing for big pharma to buy out Aurora.

NB1017 wrote:
Just opening a conversation here, what are your thoughts on Aurora funding a buy out of a US company such as MedMen through Australis or Choom? https://www.cnbc.com/2019/03/28/medmens-financial-troubles-are-a-warning-for-the-marijuana-industry.html